J Frontier Co.,Ltd. (TYO:2934)
Japan · Delayed Price · Currency is JPY 1,966.00
-16.00 (-0.81%)
Aug 6, 2026, 11:28 AM JST
J Frontier Financials Overview
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Revenue Revenue Growth | 22,235 | 22,235 | 21,504 | 17,714 | 16,844 | 11,876 |
Revenue Growth | 3.40% | 3.40% | 21.40% | 5.17% | 41.83% | 128.49% |
Gross Profit Gross Profit Growth | 8,980 | 8,980 | 9,574 | 8,333 | 7,116 | 5,398 |
Operating Income Operating Income Growth | 310 | 310 | 294 | -579 | -1,817 | 731 |
Net Income Net Income Growth | -321 | -321 | 87 | -2,086 | -1,899 | 400 |
Earnings Per Share EPS Growth | -60.58 | -60.58 | 17.21 | -425.98 | -410.40 | 86.68 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 |
|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 |
Medical Care Sales Business Medical Care Sales Business Growth | 5,288 | 5,288 |
Health Care Marketing Business Health Care Marketing Business Growth | 11,686 | 11,686 |
Health Care Sales Business Health Care Sales Business Growth | 5,404 | 5,404 |
Unallocated Adjustment Unallocated Adjustment Growth | -142.26 | -142.26 |
Total Total Growth | 22,236 | 22,236 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,158 | 2,158 | 2,169 | 1,812 | 1,648 | 2,956 |
Total Debt Total Debt Growth | 5,305 | 5,305 | 4,341 | 5,166 | 2,134 | 545 |
Net Cash (Debt) Net Cash Growth | -3,147 | -3,147 | -2,172 | -3,354 | -486 | 2,411 |
Net Cash Growth | - | - | - | - | - | 229.56% |
Net Cash Per Share Net Cash Per Share Growth | -593.88 | -593.88 | -429.66 | -684.91 | -105.03 | 521.77 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 454 | 454 | 509 | -1,435 | -1,830 | -366 |
Capital Expenditures CapEx Growth | -59 | -59 | -38 | -91 | -100 | -8 |
Free Cash Flow Free Cash Flow Growth | 395 | 395 | 471 | -1,526 | -1,930 | -374 |
Free Cash Flow Growth | -16.14% | -16.14% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Gross Margin | 40.39% | 40.39% | 44.52% | 47.04% | 42.25% | 45.45% |
Operating Margin | 1.39% | 1.39% | 1.37% | -3.27% | -10.79% | 6.16% |
Pretax Margin | -0.45% | -0.45% | 1.15% | -9.38% | -10.97% | 5.90% |
Profit Margin | -1.44% | -1.44% | 0.40% | -11.78% | -11.27% | 3.37% |
FCF Margin | 1.78% | 1.78% | 2.19% | -8.62% | -11.46% | -3.15% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | - | - | 96.42 | - | - | 26.22 |
Forward PE | - | 44.25 | 44.25 | 44.25 | - | - |
P/FCF Ratio | 26.78 | 21.82 | 17.81 | - | - | - |
PS Ratio | 0.48 | 0.39 | 0.39 | 0.66 | 0.66 | 0.88 |